Global Progesterone Injection Market Growth 2026-2032
The global Progesterone Injection market size is predicted to grow from US$ 798 million in 2025 to US$ 1112 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.
Progesterone Injection is typically formulated as an oil-based intramuscular injection, providing systemic progesterone supplementation for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and other clinical settings requiring rapid or stable plasma progesterone levels. It represents a long-established and clinically mature dosage form with widespread historical use. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), vegetable or synthetic oil vehicles, antioxidants and stabilizers, injectable glass vials, rubber stoppers and aluminum seals, as well as sterile filtration and filling consumables; material costs are relatively low, while sterile manufacturing assurance, oil-phase stability and batch-to-batch consistency are critical quality control elements. Downstream customers mainly include OB-GYN hospitals, fertility clinics, and inpatient and outpatient departments of general hospitals, with continued utilization in regions where alternative dosage forms are less accessible or adherence considerations are secondary. On a due-diligence-grade estimation basis, global nameplate capacity for Progesterone Injection in 2025 is estimated at 0.62 billion units, with actual sales of approximately 0.51 billion units. Driven by extensive generic competition and regional pricing structures, the global average ex-factory price is estimated at USD 1.6 per unit. Overall industry gross margin is estimated at approximately 41%.
The market is characterized by a mature and highly standardized landscape, with supply dominated by multi-regional generic manufacturers and broad product availability. Pricing competition is well established, and clinical use is largely confined to defined settings within obstetrics, gynecology, and reproductive medicine. In many regions, injectable progesterone remains a recognized baseline option, although prescribing decisions have become increasingly selective as treatment pathways evolve. The growing adoption of alternative dosage forms has gradually reshaped the market structure, reducing the central role of injectable therapies without eliminating their presence.
Looking forward, the market is expected to remain broadly stable or experience gradual change rather than significant expansion. Healthcare systems are increasingly prioritizing patient comfort, convenience, and adherence, which favors less invasive administration routes and limits the upside potential for injectables. Nevertheless, in clinical situations requiring rapid onset, predictable systemic exposure, or where medical resources are constrained, injectable formulations continue to offer functional advantages, preventing a sharp contraction in demand.
Key drivers include the ongoing need for reproductive health services, long-standing reliance on standardized treatment protocols, and clinical confidence in the reliability of injectable delivery in specific scenarios. In certain emerging markets and lower-tier healthcare settings, injectables remain attractive due to supply stability, clinical familiarity, and immediate therapeutic effect, providing a structural base of demand that supports market continuity.
At the same time, the market faces notable constraints. Declining patient acceptance of invasive treatments, concerns among healthcare providers regarding administration burden and safety, and tightening reimbursement and regulatory environments all exert downward pressure on usage. Moreover, continued improvements in oral and local delivery options are eroding the relative advantages of injectable therapies in some indications, resulting in a market that is structurally under pressure yet retains a degree of resilience.
LP Information, Inc. (LPI) ' newest research report, the ?Progesterone Injection Industry Forecast? looks at past sales and reviews total world Progesterone Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Progesterone Injection sales for 2026 through 2032. With Progesterone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Progesterone Injection industry.
This Insight Report provides a comprehensive analysis of the global Progesterone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Progesterone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Progesterone Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Progesterone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Progesterone Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Progesterone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Progesterone Injection market?
What factors are driving Progesterone Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Progesterone Injection market opportunities vary by end market size?
How does Progesterone Injection break out by Type, by Application?
Progesterone Injection is typically formulated as an oil-based intramuscular injection, providing systemic progesterone supplementation for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and other clinical settings requiring rapid or stable plasma progesterone levels. It represents a long-established and clinically mature dosage form with widespread historical use. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), vegetable or synthetic oil vehicles, antioxidants and stabilizers, injectable glass vials, rubber stoppers and aluminum seals, as well as sterile filtration and filling consumables; material costs are relatively low, while sterile manufacturing assurance, oil-phase stability and batch-to-batch consistency are critical quality control elements. Downstream customers mainly include OB-GYN hospitals, fertility clinics, and inpatient and outpatient departments of general hospitals, with continued utilization in regions where alternative dosage forms are less accessible or adherence considerations are secondary. On a due-diligence-grade estimation basis, global nameplate capacity for Progesterone Injection in 2025 is estimated at 0.62 billion units, with actual sales of approximately 0.51 billion units. Driven by extensive generic competition and regional pricing structures, the global average ex-factory price is estimated at USD 1.6 per unit. Overall industry gross margin is estimated at approximately 41%.
The market is characterized by a mature and highly standardized landscape, with supply dominated by multi-regional generic manufacturers and broad product availability. Pricing competition is well established, and clinical use is largely confined to defined settings within obstetrics, gynecology, and reproductive medicine. In many regions, injectable progesterone remains a recognized baseline option, although prescribing decisions have become increasingly selective as treatment pathways evolve. The growing adoption of alternative dosage forms has gradually reshaped the market structure, reducing the central role of injectable therapies without eliminating their presence.
Looking forward, the market is expected to remain broadly stable or experience gradual change rather than significant expansion. Healthcare systems are increasingly prioritizing patient comfort, convenience, and adherence, which favors less invasive administration routes and limits the upside potential for injectables. Nevertheless, in clinical situations requiring rapid onset, predictable systemic exposure, or where medical resources are constrained, injectable formulations continue to offer functional advantages, preventing a sharp contraction in demand.
Key drivers include the ongoing need for reproductive health services, long-standing reliance on standardized treatment protocols, and clinical confidence in the reliability of injectable delivery in specific scenarios. In certain emerging markets and lower-tier healthcare settings, injectables remain attractive due to supply stability, clinical familiarity, and immediate therapeutic effect, providing a structural base of demand that supports market continuity.
At the same time, the market faces notable constraints. Declining patient acceptance of invasive treatments, concerns among healthcare providers regarding administration burden and safety, and tightening reimbursement and regulatory environments all exert downward pressure on usage. Moreover, continued improvements in oral and local delivery options are eroding the relative advantages of injectable therapies in some indications, resulting in a market that is structurally under pressure yet retains a degree of resilience.
LP Information, Inc. (LPI) ' newest research report, the ?Progesterone Injection Industry Forecast? looks at past sales and reviews total world Progesterone Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Progesterone Injection sales for 2026 through 2032. With Progesterone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Progesterone Injection industry.
This Insight Report provides a comprehensive analysis of the global Progesterone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Progesterone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Progesterone Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Progesterone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Progesterone Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Progesterone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Originator Products
- Branded Generics
- Oil-based Intramuscular Injection
- Other
- Luteal Phase Support in Assisted Reproductive Technology
- Treatment of Luteal Phase Deficiency
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Besins Healthcare
- Organon
- Pfizer
- Sun Pharmaceutical Industries
- Zydus Lifesciences
- Cipla
- Intas Pharmaceuticals
- Zhejiang Xianju Pharmaceutical
- Grand Pharmaceutical Group
- Livzon
What is the 10-year outlook for the global Progesterone Injection market?
What factors are driving Progesterone Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Progesterone Injection market opportunities vary by end market size?
How does Progesterone Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Progesterone Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Progesterone Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Progesterone Injection by Country/Region, 2021, 2025 & 2032
2.2 Progesterone Injection Segment by Type
2.2.1 Originator Products
2.2.2 Branded Generics
2.2.3 Progesterone Injection Sales by Type
2.2.3.1 Global Progesterone Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Progesterone Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Progesterone Injection Sale Price by Type (2021-2026)
2.3 Progesterone Injection Segment by Formulation
2.3.1 Oil-based Intramuscular Injection
2.3.2 Other
2.3.3 Progesterone Injection Sales by Formulation
2.3.3.1 Global Progesterone Injection Sales Market Share by Formulation (2021-2026)
2.3.3.2 Global Progesterone Injection Revenue and Market Share by Formulation (2021-2026)
2.3.3.3 Global Progesterone Injection Sale Price by Formulation (2021-2026)
2.4 Progesterone Injection Segment by Clinical Indication
2.4.1 Luteal Phase Support in Assisted Reproductive Technology
2.4.2 Treatment of Luteal Phase Deficiency
2.4.3 Others
2.4.4 Progesterone Injection Sales by Clinical Indication
2.4.4.1 Global Progesterone Injection Sales Market Share by Clinical Indication (2021-2026)
2.4.4.2 Global Progesterone Injection Revenue and Market Share by Clinical Indication (2021-2026)
2.4.4.3 Global Progesterone Injection Sale Price by Clinical Indication (2021-2026)
2.5 Progesterone Injection Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Progesterone Injection Sales by Application
2.5.4.1 Global Progesterone Injection Sale Market Share by Application (2021-2026)
2.5.4.2 Global Progesterone Injection Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Progesterone Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Progesterone Injection Breakdown Data by Company
3.1.1 Global Progesterone Injection Annual Sales by Company (2021-2026)
3.1.2 Global Progesterone Injection Sales Market Share by Company (2021-2026)
3.2 Global Progesterone Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Progesterone Injection Revenue by Company (2021-2026)
3.2.2 Global Progesterone Injection Revenue Market Share by Company (2021-2026)
3.3 Global Progesterone Injection Sale Price by Company
3.4 Key Manufacturers Progesterone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Progesterone Injection Product Location Distribution
3.4.2 Players Progesterone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROGESTERONE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Progesterone Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Progesterone Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Progesterone Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Progesterone Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Progesterone Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Progesterone Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Progesterone Injection Sales Growth
4.4 APAC Progesterone Injection Sales Growth
4.5 Europe Progesterone Injection Sales Growth
4.6 Middle East & Africa Progesterone Injection Sales Growth
5 AMERICAS
5.1 Americas Progesterone Injection Sales by Country
5.1.1 Americas Progesterone Injection Sales by Country (2021-2026)
5.1.2 Americas Progesterone Injection Revenue by Country (2021-2026)
5.2 Americas Progesterone Injection Sales by Type (2021-2026)
5.3 Americas Progesterone Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Progesterone Injection Sales by Region
6.1.1 APAC Progesterone Injection Sales by Region (2021-2026)
6.1.2 APAC Progesterone Injection Revenue by Region (2021-2026)
6.2 APAC Progesterone Injection Sales by Type (2021-2026)
6.3 APAC Progesterone Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Progesterone Injection by Country
7.1.1 Europe Progesterone Injection Sales by Country (2021-2026)
7.1.2 Europe Progesterone Injection Revenue by Country (2021-2026)
7.2 Europe Progesterone Injection Sales by Type (2021-2026)
7.3 Europe Progesterone Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Progesterone Injection by Country
8.1.1 Middle East & Africa Progesterone Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Progesterone Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Progesterone Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Progesterone Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Progesterone Injection
10.3 Manufacturing Process Analysis of Progesterone Injection
10.4 Industry Chain Structure of Progesterone Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Progesterone Injection Distributors
11.3 Progesterone Injection Customer
12 WORLD FORECAST REVIEW FOR PROGESTERONE INJECTION BY GEOGRAPHIC REGION
12.1 Global Progesterone Injection Market Size Forecast by Region
12.1.1 Global Progesterone Injection Forecast by Region (2027-2032)
12.1.2 Global Progesterone Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Progesterone Injection Forecast by Type (2027-2032)
12.7 Global Progesterone Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Besins Healthcare
13.1.1 Besins Healthcare Company Information
13.1.2 Besins Healthcare Progesterone Injection Product Portfolios and Specifications
13.1.3 Besins Healthcare Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Besins Healthcare Main Business Overview
13.1.5 Besins Healthcare Latest Developments
13.2 Organon
13.2.1 Organon Company Information
13.2.2 Organon Progesterone Injection Product Portfolios and Specifications
13.2.3 Organon Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Organon Main Business Overview
13.2.5 Organon Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Progesterone Injection Product Portfolios and Specifications
13.3.3 Pfizer Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sun Pharmaceutical Industries
13.4.1 Sun Pharmaceutical Industries Company Information
13.4.2 Sun Pharmaceutical Industries Progesterone Injection Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sun Pharmaceutical Industries Main Business Overview
13.4.5 Sun Pharmaceutical Industries Latest Developments
13.5 Zydus Lifesciences
13.5.1 Zydus Lifesciences Company Information
13.5.2 Zydus Lifesciences Progesterone Injection Product Portfolios and Specifications
13.5.3 Zydus Lifesciences Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zydus Lifesciences Main Business Overview
13.5.5 Zydus Lifesciences Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Progesterone Injection Product Portfolios and Specifications
13.6.3 Cipla Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Intas Pharmaceuticals
13.7.1 Intas Pharmaceuticals Company Information
13.7.2 Intas Pharmaceuticals Progesterone Injection Product Portfolios and Specifications
13.7.3 Intas Pharmaceuticals Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Intas Pharmaceuticals Main Business Overview
13.7.5 Intas Pharmaceuticals Latest Developments
13.8 Zhejiang Xianju Pharmaceutical
13.8.1 Zhejiang Xianju Pharmaceutical Company Information
13.8.2 Zhejiang Xianju Pharmaceutical Progesterone Injection Product Portfolios and Specifications
13.8.3 Zhejiang Xianju Pharmaceutical Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.8.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.9 Grand Pharmaceutical Group
13.9.1 Grand Pharmaceutical Group Company Information
13.9.2 Grand Pharmaceutical Group Progesterone Injection Product Portfolios and Specifications
13.9.3 Grand Pharmaceutical Group Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Grand Pharmaceutical Group Main Business Overview
13.9.5 Grand Pharmaceutical Group Latest Developments
13.10 Livzon
13.10.1 Livzon Company Information
13.10.2 Livzon Progesterone Injection Product Portfolios and Specifications
13.10.3 Livzon Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Livzon Main Business Overview
13.10.5 Livzon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Progesterone Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Progesterone Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Progesterone Injection by Country/Region, 2021, 2025 & 2032
2.2 Progesterone Injection Segment by Type
2.2.1 Originator Products
2.2.2 Branded Generics
2.2.3 Progesterone Injection Sales by Type
2.2.3.1 Global Progesterone Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Progesterone Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Progesterone Injection Sale Price by Type (2021-2026)
2.3 Progesterone Injection Segment by Formulation
2.3.1 Oil-based Intramuscular Injection
2.3.2 Other
2.3.3 Progesterone Injection Sales by Formulation
2.3.3.1 Global Progesterone Injection Sales Market Share by Formulation (2021-2026)
2.3.3.2 Global Progesterone Injection Revenue and Market Share by Formulation (2021-2026)
2.3.3.3 Global Progesterone Injection Sale Price by Formulation (2021-2026)
2.4 Progesterone Injection Segment by Clinical Indication
2.4.1 Luteal Phase Support in Assisted Reproductive Technology
2.4.2 Treatment of Luteal Phase Deficiency
2.4.3 Others
2.4.4 Progesterone Injection Sales by Clinical Indication
2.4.4.1 Global Progesterone Injection Sales Market Share by Clinical Indication (2021-2026)
2.4.4.2 Global Progesterone Injection Revenue and Market Share by Clinical Indication (2021-2026)
2.4.4.3 Global Progesterone Injection Sale Price by Clinical Indication (2021-2026)
2.5 Progesterone Injection Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Progesterone Injection Sales by Application
2.5.4.1 Global Progesterone Injection Sale Market Share by Application (2021-2026)
2.5.4.2 Global Progesterone Injection Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Progesterone Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Progesterone Injection Breakdown Data by Company
3.1.1 Global Progesterone Injection Annual Sales by Company (2021-2026)
3.1.2 Global Progesterone Injection Sales Market Share by Company (2021-2026)
3.2 Global Progesterone Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Progesterone Injection Revenue by Company (2021-2026)
3.2.2 Global Progesterone Injection Revenue Market Share by Company (2021-2026)
3.3 Global Progesterone Injection Sale Price by Company
3.4 Key Manufacturers Progesterone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Progesterone Injection Product Location Distribution
3.4.2 Players Progesterone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROGESTERONE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Progesterone Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Progesterone Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Progesterone Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Progesterone Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Progesterone Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Progesterone Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Progesterone Injection Sales Growth
4.4 APAC Progesterone Injection Sales Growth
4.5 Europe Progesterone Injection Sales Growth
4.6 Middle East & Africa Progesterone Injection Sales Growth
5 AMERICAS
5.1 Americas Progesterone Injection Sales by Country
5.1.1 Americas Progesterone Injection Sales by Country (2021-2026)
5.1.2 Americas Progesterone Injection Revenue by Country (2021-2026)
5.2 Americas Progesterone Injection Sales by Type (2021-2026)
5.3 Americas Progesterone Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Progesterone Injection Sales by Region
6.1.1 APAC Progesterone Injection Sales by Region (2021-2026)
6.1.2 APAC Progesterone Injection Revenue by Region (2021-2026)
6.2 APAC Progesterone Injection Sales by Type (2021-2026)
6.3 APAC Progesterone Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Progesterone Injection by Country
7.1.1 Europe Progesterone Injection Sales by Country (2021-2026)
7.1.2 Europe Progesterone Injection Revenue by Country (2021-2026)
7.2 Europe Progesterone Injection Sales by Type (2021-2026)
7.3 Europe Progesterone Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Progesterone Injection by Country
8.1.1 Middle East & Africa Progesterone Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Progesterone Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Progesterone Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Progesterone Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Progesterone Injection
10.3 Manufacturing Process Analysis of Progesterone Injection
10.4 Industry Chain Structure of Progesterone Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Progesterone Injection Distributors
11.3 Progesterone Injection Customer
12 WORLD FORECAST REVIEW FOR PROGESTERONE INJECTION BY GEOGRAPHIC REGION
12.1 Global Progesterone Injection Market Size Forecast by Region
12.1.1 Global Progesterone Injection Forecast by Region (2027-2032)
12.1.2 Global Progesterone Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Progesterone Injection Forecast by Type (2027-2032)
12.7 Global Progesterone Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Besins Healthcare
13.1.1 Besins Healthcare Company Information
13.1.2 Besins Healthcare Progesterone Injection Product Portfolios and Specifications
13.1.3 Besins Healthcare Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Besins Healthcare Main Business Overview
13.1.5 Besins Healthcare Latest Developments
13.2 Organon
13.2.1 Organon Company Information
13.2.2 Organon Progesterone Injection Product Portfolios and Specifications
13.2.3 Organon Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Organon Main Business Overview
13.2.5 Organon Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Progesterone Injection Product Portfolios and Specifications
13.3.3 Pfizer Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sun Pharmaceutical Industries
13.4.1 Sun Pharmaceutical Industries Company Information
13.4.2 Sun Pharmaceutical Industries Progesterone Injection Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sun Pharmaceutical Industries Main Business Overview
13.4.5 Sun Pharmaceutical Industries Latest Developments
13.5 Zydus Lifesciences
13.5.1 Zydus Lifesciences Company Information
13.5.2 Zydus Lifesciences Progesterone Injection Product Portfolios and Specifications
13.5.3 Zydus Lifesciences Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zydus Lifesciences Main Business Overview
13.5.5 Zydus Lifesciences Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Progesterone Injection Product Portfolios and Specifications
13.6.3 Cipla Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Intas Pharmaceuticals
13.7.1 Intas Pharmaceuticals Company Information
13.7.2 Intas Pharmaceuticals Progesterone Injection Product Portfolios and Specifications
13.7.3 Intas Pharmaceuticals Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Intas Pharmaceuticals Main Business Overview
13.7.5 Intas Pharmaceuticals Latest Developments
13.8 Zhejiang Xianju Pharmaceutical
13.8.1 Zhejiang Xianju Pharmaceutical Company Information
13.8.2 Zhejiang Xianju Pharmaceutical Progesterone Injection Product Portfolios and Specifications
13.8.3 Zhejiang Xianju Pharmaceutical Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.8.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.9 Grand Pharmaceutical Group
13.9.1 Grand Pharmaceutical Group Company Information
13.9.2 Grand Pharmaceutical Group Progesterone Injection Product Portfolios and Specifications
13.9.3 Grand Pharmaceutical Group Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Grand Pharmaceutical Group Main Business Overview
13.9.5 Grand Pharmaceutical Group Latest Developments
13.10 Livzon
13.10.1 Livzon Company Information
13.10.2 Livzon Progesterone Injection Product Portfolios and Specifications
13.10.3 Livzon Progesterone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Livzon Main Business Overview
13.10.5 Livzon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Progesterone Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Progesterone Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Originator Products
Table 4. Major Players of Branded Generics
Table 5. Global Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Progesterone Injection Sales Market Share by Type (2021-2026)
Table 7. Global Progesterone Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Progesterone Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Progesterone Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oil-based Intramuscular Injection
Table 11. Major Players of Other
Table 12. Global Progesterone Injection Sales by Formulation (2021-2026) & (K Units)
Table 13. Global Progesterone Injection Sales Market Share by Formulation (2021-2026)
Table 14. Global Progesterone Injection Revenue by Formulation (2021-2026) & ($ million)
Table 15. Global Progesterone Injection Revenue Market Share by Formulation (2021-2026)
Table 16. Global Progesterone Injection Sale Price by Formulation (2021-2026) & (US$/Unit)
Table 17. Major Players of Luteal Phase Support in Assisted Reproductive Technology
Table 18. Major Players of Treatment of Luteal Phase Deficiency
Table 19. Major Players of Others
Table 20. Global Progesterone Injection Sales by Clinical Indication (2021-2026) & (K Units)
Table 21. Global Progesterone Injection Sales Market Share by Clinical Indication (2021-2026)
Table 22. Global Progesterone Injection Revenue by Clinical Indication (2021-2026) & ($ million)
Table 23. Global Progesterone Injection Revenue Market Share by Clinical Indication (2021-2026)
Table 24. Global Progesterone Injection Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 25. Global Progesterone Injection Sale by Application (2021-2026) & (K Units)
Table 26. Global Progesterone Injection Sale Market Share by Application (2021-2026)
Table 27. Global Progesterone Injection Revenue by Application (2021-2026) & ($ million)
Table 28. Global Progesterone Injection Revenue Market Share by Application (2021-2026)
Table 29. Global Progesterone Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Progesterone Injection Sales by Company (2021-2026) & (K Units)
Table 31. Global Progesterone Injection Sales Market Share by Company (2021-2026)
Table 32. Global Progesterone Injection Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Progesterone Injection Revenue Market Share by Company (2021-2026)
Table 34. Global Progesterone Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Progesterone Injection Producing Area Distribution and Sales Area
Table 36. Players Progesterone Injection Products Offered
Table 37. Progesterone Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Progesterone Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Progesterone Injection Sales Market Share Geographic Region (2021-2026)
Table 42. Global Progesterone Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Progesterone Injection Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Progesterone Injection Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Progesterone Injection Sales Market Share by Country/Region (2021-2026)
Table 46. Global Progesterone Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Progesterone Injection Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 49. Americas Progesterone Injection Sales Market Share by Country (2021-2026)
Table 50. Americas Progesterone Injection Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 52. Americas Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 53. APAC Progesterone Injection Sales by Region (2021-2026) & (K Units)
Table 54. APAC Progesterone Injection Sales Market Share by Region (2021-2026)
Table 55. APAC Progesterone Injection Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 57. APAC Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 58. Europe Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 59. Europe Progesterone Injection Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 61. Europe Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Progesterone Injection Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Progesterone Injection
Table 67. Key Market Challenges & Risks of Progesterone Injection
Table 68. Key Industry Trends of Progesterone Injection
Table 69. Progesterone Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Progesterone Injection Distributors List
Table 72. Progesterone Injection Customer List
Table 73. Global Progesterone Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Progesterone Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Progesterone Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Progesterone Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Progesterone Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Progesterone Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Progesterone Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Progesterone Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Progesterone Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Progesterone Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Progesterone Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Besins Healthcare Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Besins Healthcare Progesterone Injection Product Portfolios and Specifications
Table 89. Besins Healthcare Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Besins Healthcare Main Business
Table 91. Besins Healthcare Latest Developments
Table 92. Organon Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Organon Progesterone Injection Product Portfolios and Specifications
Table 94. Organon Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Organon Main Business
Table 96. Organon Latest Developments
Table 97. Pfizer Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Progesterone Injection Product Portfolios and Specifications
Table 99. Pfizer Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Sun Pharmaceutical Industries Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Industries Progesterone Injection Product Portfolios and Specifications
Table 104. Sun Pharmaceutical Industries Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sun Pharmaceutical Industries Main Business
Table 106. Sun Pharmaceutical Industries Latest Developments
Table 107. Zydus Lifesciences Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Zydus Lifesciences Progesterone Injection Product Portfolios and Specifications
Table 109. Zydus Lifesciences Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Zydus Lifesciences Main Business
Table 111. Zydus Lifesciences Latest Developments
Table 112. Cipla Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Cipla Progesterone Injection Product Portfolios and Specifications
Table 114. Cipla Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. Intas Pharmaceuticals Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Intas Pharmaceuticals Progesterone Injection Product Portfolios and Specifications
Table 119. Intas Pharmaceuticals Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Intas Pharmaceuticals Main Business
Table 121. Intas Pharmaceuticals Latest Developments
Table 122. Zhejiang Xianju Pharmaceutical Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Zhejiang Xianju Pharmaceutical Progesterone Injection Product Portfolios and Specifications
Table 124. Zhejiang Xianju Pharmaceutical Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Zhejiang Xianju Pharmaceutical Main Business
Table 126. Zhejiang Xianju Pharmaceutical Latest Developments
Table 127. Grand Pharmaceutical Group Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Grand Pharmaceutical Group Progesterone Injection Product Portfolios and Specifications
Table 129. Grand Pharmaceutical Group Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Grand Pharmaceutical Group Main Business
Table 131. Grand Pharmaceutical Group Latest Developments
Table 132. Livzon Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Livzon Progesterone Injection Product Portfolios and Specifications
Table 134. Livzon Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Livzon Main Business
Table 136. Livzon Latest Developments
Table 1. Progesterone Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Progesterone Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Originator Products
Table 4. Major Players of Branded Generics
Table 5. Global Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Progesterone Injection Sales Market Share by Type (2021-2026)
Table 7. Global Progesterone Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Progesterone Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Progesterone Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oil-based Intramuscular Injection
Table 11. Major Players of Other
Table 12. Global Progesterone Injection Sales by Formulation (2021-2026) & (K Units)
Table 13. Global Progesterone Injection Sales Market Share by Formulation (2021-2026)
Table 14. Global Progesterone Injection Revenue by Formulation (2021-2026) & ($ million)
Table 15. Global Progesterone Injection Revenue Market Share by Formulation (2021-2026)
Table 16. Global Progesterone Injection Sale Price by Formulation (2021-2026) & (US$/Unit)
Table 17. Major Players of Luteal Phase Support in Assisted Reproductive Technology
Table 18. Major Players of Treatment of Luteal Phase Deficiency
Table 19. Major Players of Others
Table 20. Global Progesterone Injection Sales by Clinical Indication (2021-2026) & (K Units)
Table 21. Global Progesterone Injection Sales Market Share by Clinical Indication (2021-2026)
Table 22. Global Progesterone Injection Revenue by Clinical Indication (2021-2026) & ($ million)
Table 23. Global Progesterone Injection Revenue Market Share by Clinical Indication (2021-2026)
Table 24. Global Progesterone Injection Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 25. Global Progesterone Injection Sale by Application (2021-2026) & (K Units)
Table 26. Global Progesterone Injection Sale Market Share by Application (2021-2026)
Table 27. Global Progesterone Injection Revenue by Application (2021-2026) & ($ million)
Table 28. Global Progesterone Injection Revenue Market Share by Application (2021-2026)
Table 29. Global Progesterone Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Progesterone Injection Sales by Company (2021-2026) & (K Units)
Table 31. Global Progesterone Injection Sales Market Share by Company (2021-2026)
Table 32. Global Progesterone Injection Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Progesterone Injection Revenue Market Share by Company (2021-2026)
Table 34. Global Progesterone Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Progesterone Injection Producing Area Distribution and Sales Area
Table 36. Players Progesterone Injection Products Offered
Table 37. Progesterone Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Progesterone Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Progesterone Injection Sales Market Share Geographic Region (2021-2026)
Table 42. Global Progesterone Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Progesterone Injection Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Progesterone Injection Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Progesterone Injection Sales Market Share by Country/Region (2021-2026)
Table 46. Global Progesterone Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Progesterone Injection Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 49. Americas Progesterone Injection Sales Market Share by Country (2021-2026)
Table 50. Americas Progesterone Injection Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 52. Americas Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 53. APAC Progesterone Injection Sales by Region (2021-2026) & (K Units)
Table 54. APAC Progesterone Injection Sales Market Share by Region (2021-2026)
Table 55. APAC Progesterone Injection Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 57. APAC Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 58. Europe Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 59. Europe Progesterone Injection Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 61. Europe Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Progesterone Injection Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Progesterone Injection Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Progesterone Injection Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Progesterone Injection Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Progesterone Injection
Table 67. Key Market Challenges & Risks of Progesterone Injection
Table 68. Key Industry Trends of Progesterone Injection
Table 69. Progesterone Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Progesterone Injection Distributors List
Table 72. Progesterone Injection Customer List
Table 73. Global Progesterone Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Progesterone Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Progesterone Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Progesterone Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Progesterone Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Progesterone Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Progesterone Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Progesterone Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Progesterone Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Progesterone Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Progesterone Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Progesterone Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Besins Healthcare Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Besins Healthcare Progesterone Injection Product Portfolios and Specifications
Table 89. Besins Healthcare Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Besins Healthcare Main Business
Table 91. Besins Healthcare Latest Developments
Table 92. Organon Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Organon Progesterone Injection Product Portfolios and Specifications
Table 94. Organon Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Organon Main Business
Table 96. Organon Latest Developments
Table 97. Pfizer Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Progesterone Injection Product Portfolios and Specifications
Table 99. Pfizer Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Sun Pharmaceutical Industries Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Industries Progesterone Injection Product Portfolios and Specifications
Table 104. Sun Pharmaceutical Industries Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sun Pharmaceutical Industries Main Business
Table 106. Sun Pharmaceutical Industries Latest Developments
Table 107. Zydus Lifesciences Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Zydus Lifesciences Progesterone Injection Product Portfolios and Specifications
Table 109. Zydus Lifesciences Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Zydus Lifesciences Main Business
Table 111. Zydus Lifesciences Latest Developments
Table 112. Cipla Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Cipla Progesterone Injection Product Portfolios and Specifications
Table 114. Cipla Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. Intas Pharmaceuticals Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Intas Pharmaceuticals Progesterone Injection Product Portfolios and Specifications
Table 119. Intas Pharmaceuticals Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Intas Pharmaceuticals Main Business
Table 121. Intas Pharmaceuticals Latest Developments
Table 122. Zhejiang Xianju Pharmaceutical Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Zhejiang Xianju Pharmaceutical Progesterone Injection Product Portfolios and Specifications
Table 124. Zhejiang Xianju Pharmaceutical Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Zhejiang Xianju Pharmaceutical Main Business
Table 126. Zhejiang Xianju Pharmaceutical Latest Developments
Table 127. Grand Pharmaceutical Group Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Grand Pharmaceutical Group Progesterone Injection Product Portfolios and Specifications
Table 129. Grand Pharmaceutical Group Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Grand Pharmaceutical Group Main Business
Table 131. Grand Pharmaceutical Group Latest Developments
Table 132. Livzon Basic Information, Progesterone Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Livzon Progesterone Injection Product Portfolios and Specifications
Table 134. Livzon Progesterone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Livzon Main Business
Table 136. Livzon Latest Developments
LIST OF FIGURES
Figure 1. Picture of Progesterone Injection
Figure 2. Progesterone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Progesterone Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Progesterone Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Progesterone Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Progesterone Injection Sales Market Share by Country/Region (2025)
Figure 10. Progesterone Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Originator Products
Figure 12. Product Picture of Branded Generics
Figure 13. Global Progesterone Injection Sales Market Share by Type in 2026
Figure 14. Global Progesterone Injection Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oil-based Intramuscular Injection
Figure 16. Product Picture of Other
Figure 17. Global Progesterone Injection Sales Market Share by Formulation in 2026
Figure 18. Global Progesterone Injection Revenue Market Share by Formulation (2021-2026)
Figure 19. Product Picture of Luteal Phase Support in Assisted Reproductive Technology
Figure 20. Product Picture of Treatment of Luteal Phase Deficiency
Figure 21. Product Picture of Others
Figure 22. Global Progesterone Injection Sales Market Share by Clinical Indication in 2026
Figure 23. Global Progesterone Injection Revenue Market Share by Clinical Indication (2021-2026)
Figure 24. Progesterone Injection Consumed in Hospital
Figure 25. Global Progesterone Injection Market: Hospital (2021-2026) & (K Units)
Figure 26. Progesterone Injection Consumed in Clinic
Figure 27. Global Progesterone Injection Market: Clinic (2021-2026) & (K Units)
Figure 28. Progesterone Injection Consumed in Others
Figure 29. Global Progesterone Injection Market: Others (2021-2026) & (K Units)
Figure 30. Global Progesterone Injection Sale Market Share by Application (2025)
Figure 31. Global Progesterone Injection Revenue Market Share by Application in 2025
Figure 32. Progesterone Injection Sales by Company in 2025 (K Units)
Figure 33. Global Progesterone Injection Sales Market Share by Company in 2025
Figure 34. Progesterone Injection Revenue by Company in 2025 ($ millions)
Figure 35. Global Progesterone Injection Revenue Market Share by Company in 2025
Figure 36. Global Progesterone Injection Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Progesterone Injection Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Progesterone Injection Sales 2021-2026 (K Units)
Figure 39. Americas Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 40. APAC Progesterone Injection Sales 2021-2026 (K Units)
Figure 41. APAC Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 42. Europe Progesterone Injection Sales 2021-2026 (K Units)
Figure 43. Europe Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Progesterone Injection Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 46. Americas Progesterone Injection Sales Market Share by Country in 2025
Figure 47. Americas Progesterone Injection Revenue Market Share by Country (2021-2026)
Figure 48. Americas Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 49. Americas Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 50. United States Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Progesterone Injection Sales Market Share by Region in 2025
Figure 55. APAC Progesterone Injection Revenue Market Share by Region (2021-2026)
Figure 56. APAC Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 57. APAC Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 58. China Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. India Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Progesterone Injection Sales Market Share by Country in 2025
Figure 66. Europe Progesterone Injection Revenue Market Share by Country (2021-2026)
Figure 67. Europe Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 68. Europe Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 69. Germany Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. France Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Progesterone Injection Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 77. Egypt Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Progesterone Injection in 2026
Figure 83. Manufacturing Process Analysis of Progesterone Injection
Figure 84. Industry Chain Structure of Progesterone Injection
Figure 85. Channels of Distribution
Figure 86. Global Progesterone Injection Sales Market Forecast by Region (2027-2032)
Figure 87. Global Progesterone Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Progesterone Injection Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Progesterone Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Progesterone Injection Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Progesterone Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Progesterone Injection
Figure 2. Progesterone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Progesterone Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Progesterone Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Progesterone Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Progesterone Injection Sales Market Share by Country/Region (2025)
Figure 10. Progesterone Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Originator Products
Figure 12. Product Picture of Branded Generics
Figure 13. Global Progesterone Injection Sales Market Share by Type in 2026
Figure 14. Global Progesterone Injection Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oil-based Intramuscular Injection
Figure 16. Product Picture of Other
Figure 17. Global Progesterone Injection Sales Market Share by Formulation in 2026
Figure 18. Global Progesterone Injection Revenue Market Share by Formulation (2021-2026)
Figure 19. Product Picture of Luteal Phase Support in Assisted Reproductive Technology
Figure 20. Product Picture of Treatment of Luteal Phase Deficiency
Figure 21. Product Picture of Others
Figure 22. Global Progesterone Injection Sales Market Share by Clinical Indication in 2026
Figure 23. Global Progesterone Injection Revenue Market Share by Clinical Indication (2021-2026)
Figure 24. Progesterone Injection Consumed in Hospital
Figure 25. Global Progesterone Injection Market: Hospital (2021-2026) & (K Units)
Figure 26. Progesterone Injection Consumed in Clinic
Figure 27. Global Progesterone Injection Market: Clinic (2021-2026) & (K Units)
Figure 28. Progesterone Injection Consumed in Others
Figure 29. Global Progesterone Injection Market: Others (2021-2026) & (K Units)
Figure 30. Global Progesterone Injection Sale Market Share by Application (2025)
Figure 31. Global Progesterone Injection Revenue Market Share by Application in 2025
Figure 32. Progesterone Injection Sales by Company in 2025 (K Units)
Figure 33. Global Progesterone Injection Sales Market Share by Company in 2025
Figure 34. Progesterone Injection Revenue by Company in 2025 ($ millions)
Figure 35. Global Progesterone Injection Revenue Market Share by Company in 2025
Figure 36. Global Progesterone Injection Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Progesterone Injection Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Progesterone Injection Sales 2021-2026 (K Units)
Figure 39. Americas Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 40. APAC Progesterone Injection Sales 2021-2026 (K Units)
Figure 41. APAC Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 42. Europe Progesterone Injection Sales 2021-2026 (K Units)
Figure 43. Europe Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Progesterone Injection Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Progesterone Injection Revenue 2021-2026 ($ millions)
Figure 46. Americas Progesterone Injection Sales Market Share by Country in 2025
Figure 47. Americas Progesterone Injection Revenue Market Share by Country (2021-2026)
Figure 48. Americas Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 49. Americas Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 50. United States Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Progesterone Injection Sales Market Share by Region in 2025
Figure 55. APAC Progesterone Injection Revenue Market Share by Region (2021-2026)
Figure 56. APAC Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 57. APAC Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 58. China Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. India Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Progesterone Injection Sales Market Share by Country in 2025
Figure 66. Europe Progesterone Injection Revenue Market Share by Country (2021-2026)
Figure 67. Europe Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 68. Europe Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 69. Germany Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. France Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Progesterone Injection Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Progesterone Injection Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Progesterone Injection Sales Market Share by Application (2021-2026)
Figure 77. Egypt Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Progesterone Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Progesterone Injection in 2026
Figure 83. Manufacturing Process Analysis of Progesterone Injection
Figure 84. Industry Chain Structure of Progesterone Injection
Figure 85. Channels of Distribution
Figure 86. Global Progesterone Injection Sales Market Forecast by Region (2027-2032)
Figure 87. Global Progesterone Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Progesterone Injection Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Progesterone Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Progesterone Injection Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Progesterone Injection Revenue Market Share Forecast by Application (2027-2032)
